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IN preceding investigations (Benassi, Perissinotto and Allegri, 1963) we studied
the excretion of tryptophan metabolites in 201 patients with bladder tumours, 55
subjects suffering from tumours of the urinary system, particularly of kidney
(Perissinotto, Benassi and Allegri, 1964), and 112 individuals with various non-
neoplastic urological diseases. Abnormal levels of urinary kynurenine, 3-hydroxy-
kynurenine and 3-hydroxyanthranilic acid were detectable in certain patients
in all three groups with a higher frequency in those with kidney neoplasm.
As a consequence of these results we doubted the relationship between the
exeretion of these metabolites and urinary tract neoplasm, and likewise it was
difficult to accept the hypothesis that quantitative variations of metabolites, as
revealed by increase of urinary products, could induce endogenous bladder
cancer.
Since the presence of metabolites in biologic fluid depends upon specific
enzyme activities we thought it ofinterest to study several ofthe enzymes involved
in the intermediary metabolism of tryptophan.
In the present investigation tryptophan pyrrolase, kynureninase, anid
kynurenine transaminase were measured in normal and neoplastic human kidneys,
since it was observed (Perissinotto et al., 1964) that a higher and more frequent
excretion of the so-called oncogenic metabolites occurred in patients with renal
neoplasm.
Tryptophan pyrrolase firstly attacks tryptophan causing oxidative breakdown
of the indole ring yielding NI-formylkynurenine. It is present in mammalian,
amphibian and avian liver and also in insects, some bacteria and fungi. Animal
kidney seems to lack such an enzyme.
It has been isolated as ferriheme inactive protein and its levels in liver are
under adaptive control: enzyme activity arises with increasing substrate con-
centration (induction by substrate) and furthermore by hormonal action (hor-
monal induction), and it is, in general terms, concerned with protein synthesis.
Kynureninase causes cleavage of the alanine chain of kynurenine and 3-
hydroxykynurenine forming anthranilic and 3-hydroxyanthranilic acids respec-
tively. It requires pyridoxal-5-phosphate as a coenzyme.
Kynurenine transaminase is also a pyridoxal-phosphate-dependent enzyme
and catalyses the transformation of kynurenine to kynurenic acid and 3-hydroxy-
kynurenine to xanthurenic acid.
* This paper was )resented to the Symposium on Tryptophan Urinary Metabolites in London
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Mammalian liver has more kynureninase than kidney in which kynurenine
transaminase is predominant although both enzymes are present in bacteria and
moulds.
MATERIALS AND METHODS
We have examined 23 renal parenchymal tumours (Table I) and 6 fragments
ofnormal tissue from kidneys with a malignancy, since it was obviously impossible
to have, as control, normal kidneys.
TABLE I.-Number and Data of Kidney Tumours
Weight
of tujmour
No. Case Age Sex Diagnosis (g.)
1 V. A. 64 F Renal careinonma . 22
2 C. S. 57 M . ,, ,, . 10
3 .G. B. 67 M 9
4 .G. A. 61 F . ,, ., 1
. G. A. 60 F ,22
6 . C. G. 62 M ,, 73
7 A. M. 55 M . ,, ,, 94
8 B. P 67 M ,, . 36
9 M. V. 58 F , , . 170
1 G P. 65 M ,, ,, . 15
11 M. M.. 56 F 0. 2
12 . B. M. 56 M. 11
13 G. R 54 M Papillary adenocarcinorna . 46
14 S. C. 64 F. Renal carcinoma . 63
15 .O.R. 47 Al , ,, 26
16 M.L 38 M ,, 100
17 B. V. 45 M . ,, 120
18 F. M. . 9. . .,, 38
19 .R. F 18 M ,, 18
20 .B. G 53 M ,, . 82
21 .M. T 67 F ,, ,, . 43
22 C. M 40 M. ,, ,, . 5
23 .C. A. 53 M ,, . 60
Immediately after nephrectomy every organ was immersed in ice and divided
into three portions, each of which was homogenized in a Waring Blendor for 2
minutes with 4 times its own weight ofice and phosphate buffer at a pH appropri-
ate for each enzyme (see below). The homogenate was diluted to a 200 (w/v)
concentration with 0*05 M buffer.
(1) Tryptophan pyrrolase was prepared and estimated according to Knox
(1955) and to Knox and Auerbach (1955) with slight modifications. A 20Y"
homogenate in 0-05 M phosphate buffer pH 7 0 was centrifuged for 10 minutes at
2500 r.p.m. and the supernatant used as the enzyme source.
The activity was determined for an incubation period of 60 minutes during
which the reaction rate remained constant. Incubations were carried out in open
Erlenmeyer flasks shaken in a water bath at 38° C. All assays were performed
with an incubation mixture of 6.4 ml. of 041 M phosphate buffer, pH 7, 0-6 ml. of
0-03 M tryptophan in 041 M phosphate buffer, pH 7, 1 ml. of enzymic preparation.
Samples were run in duplicate and 1-0 ml. aliquots were removed at zero time
for blanks and after 60 minutes ofincubation and added to small tubes containing
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centrifuged down for 10 minutes at 2000 r.p.m., and an aliquot of the clear super-
natant was analysed for kynurenine content according the method of Bratton
and Marshall (1938).
The amounts of kynurenine were estimated at 10-20 minute intervals for
approximately two hours and the results plotted against time and hence it was
possible to calculate the micromoles of kynurenine accumulating per hour for
each gram of supernatant protein.
(2) Kynureninase was prepared and measured according to a modification of
Saran's method (1958).
The frozen normal kidney and the neoplastic tissues were homogenized with
cold 0-05 M phosphate buffer, pH 8, to prepare a 20% mixture.
After freezing for a day at -20° C. it was thawed and centrifuged for 35
minutes at 9000 r.p.m. The assay mixture contained 1-0 ml. of supernatant
fraction, 0-3 ml. of 0-00004 M pyridoxal-5-phosphate in 0-05 M phosphate buffer,
pH 8, 1-6 ml. 0-05 M phosphate buffer, pH 8. After a 15 minute preincubation
period at 370 C. 0-1 ml. of 0-01 M kynurenine in 0-05 M phosphate buffer, pH 8,
was added.
From the incubation mixture were taken duplicate blanks of 1-2 ml. at zero
time and text samples after 30 minute incubation.
The samples had 0-2 ml. of 15 % TCA added immediately to stop any enzyme
reaction and were then centrifuged at 5000 r.p.m. for 10 minutes.
0.1 ml. supernatant was withdrawn and made to a final volume of 4 ml. with
0-1 M phosphate buffer, pH 8. The anthranilic acid formed was determined
spectrofluorometrically with an Aminco-Bowman apparatus at 400 m,u (excitation
310 m,t) and derived from the standard curve obtained in the same experimental
conditions.
Enzyme specific activity was expressed as flmoles of anthranilic acid formed
per g. of protein per hour.
(3) Kynurenine transaminase was prepared and estimated by the method of
Mason (1957) andwas partiallypurified by meansofammonium sulphatefractiona-
tion.
All assays were performed in triplicate, with a 1-5 ml. mixture containing
1 ml. ofenzyme solution, 0-15 ml. of 0-006 M a-ketoglutarate in 0-05 M phosphate
buffer, pH 7-4 and 0-15 ml. of 0-0004 M pyridoxal-5-phosphate in the same buffer.
After a 15 minute preincubation period at 370 C. 0-2 ml. of 0-035 M L-kyniure-
nine in 0-05 M phosphate buffer, pH 7.4, was added. The reaction was stopped at
zero time for blanks and after 30 minutes by means of 7-5 ml. of 95% ethanol
containing 1% boric acid. Previous studies demonstrated a liiiear reaction rate
during this time period.
After centrifuging at 9000 r.p.m. theformation ofkynurenic acid was measured
spectrophotometrically at 333 m,u against the blank containing the same com-
ponents and deproteinizing agent added at zero time.
The amount of kynurenic acid formed was read from a calibration curve
prepared under the same experimental conditions after adding known amounts
of kynurenic acid.
Kynurenine transaminase activity was expressed as ,tmoles of kynurenic acid
formed per g. protein per hour.
(4) The nitrogen content of enzyme solutions was determined by the micro-
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(5) The 24 hours urines before nephrectomy were analysed for their content of
tryptophan metabolites, by using the method of Benassi Veronese and Antoni
(1963-64).
RESULTS AND DISCUSSION
Table II reports data for enzymic activities: they are, to our knowledge, the
first values on tryptophan pyrrolase, kynureninase and kynurenine transaminase
in human renal tissue, from both normal and neoplastic kidneys.
TABLE II.-Enzyme Activities of Normnal and Neoplastic Kidneys
Specific activities:
Tryptophan pyrrolase*
/lM K/h./g. protein
Case ,
number Normal Neoplastic
1 . - 0-6
2 . - 0-0
3 . 0*8
4 . 0-6
5 00
6 . - 0-8
7 . 0 1-2
8 - 0.0
9 00
10 . 0-0
11 . 00
12 0 0-0
13 . - 00
14 0 0.0
15 . 0 0 0
16 0 0.0
17 0.0
18 00
19 0-0
20 . 0 0 6
21 . 00
22 . 0.0
23 00
Kynureninase*
UM AA/h. /g. protein
Normal Neoplastic
0 00
0 22
0*00
0 20
0-06
0-25
0-17 0 23
0*30
0*29
0-65
0 38
0-15 0-25
0 21
0 54 0-78
0*22 0.00
0-31 0 04
0.00
0 00
0 69
0 33 0-14
0 00
0 39
0 45
Kynurenine transaminase*
gM KA/h./g. protein
Normal Neoplastic,
* -- ~~~~87-6
18-4
3-6
39.4
0 9
5 8
2- 9 2-0
2-1
11-9
-~~~~~~ 27
- 25-2
8-.5 7 0
_ 3-1
a-3 6-8
4-.3 3.8
21 2 0.0
2-8
0.0
6-5
0.0 5 8
00
189
8-9
* Values are expressed as an average of Mmoles of compound formiied.
The following abbreviations are used: K, kynurenine; AA, anthranilic acid; KA, kynurenic acid.
In this table one can note the absence of tryptophan pyrrolase in the normal
kidney fragments. This confirms the absence of tryptophan pyrrolase in kidney
tissue and shows a similar situation in renal neoplastic tissue.
Kynureninase values show large fluctuations both in normal and neoplastic
kidney tissue. The activity does not significantly differ in normal and in onco-
genic tissues. However, the activities are much lower than those obtained in
this laboratory in analogous work on rat and guinea-pig kidney.
In the few cases in which it has been possible to isolate fragments of normal
kidney, kynureninetransaminase results are slightlylower in the neoplastic portion
than in the normal portion. However, the levels of this enzyme, somewhat
higher than kynureninase, appear markedly reduced compared with that of other
mammalian kidney when expressed as ,tmoles ofproduct per g. protein per hour.
With an aim to relate the observed enzyme activities with the carcinogenic
process the determination of main products of tryptophan degradation has been
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carried out in urine ofthe same patients 24 hours before nephrectomy and therefore
just before the determination of kidney enzymic activities.
TABLE III.-Amounts of Metabolites Excreted by 23 Subjects with Renal
Tumour 24 hours Before Nephrectomy
Case K 3 OHK 3 OHAA oAHA KA XA
No. mg./24 hr
1 . 2-10 . 0-58 . 1-80 0-87 . 1-32 0-86
2 . l9 O . 0 30 . 0-26 059 . 1-80 . 0-60
3 . 0-89 . 0-25 . 0-27 0-63 0 90 . 0-56
4 1-10 . 050 . 044 0 63 . 1-08 . 0 50
5 0-92 . 0-58 . 032 0-58 1-88 . 0-72
6 22-50 . 052 0-88 0-42 . 0 95 . 0-52
7 . 15-00 . 049 . 0 40 0-48 . -280 . 0-66
8 . 1-1() . 028 25-11 0 82 . 1 92 . 052
9 . 097 0*36 . 0-32 0-75 . 1-40 . 050
10 17-50 . 049 . 7-60 1*20 . 8-38 7-62
10* 17-50 . 0-28 6-38 097 7-57 7-24
11 0-92 . 0-26 . 0-32 1-32 0 95 0-48
12 0-98 0-42 . 869 0 63 097 0.50
13 1-22 040 0 68 0 97 1-20 0 52
14 68-75 . 0 50 2-50 1-52 . 285 . 0 70
15 2-20 . 0-80 . 0-88 35-42 . 12-58 5-26
16 1-20 049 060 0-88 1-00 . 0-60
17 . 1-14 . 052 042 0 40 282 . 072
18 3750 030 23-18 0-58 1-20 . 0-60
19 . 12-50 . 0-65 0-32 0-92 8-62 . 0-72
20 20-00 . 050 . 350 1-20 . 1-40 0*86
21 . 1-28 0-28 . 0 40 0 82 180 . 0-60
22 1-10 . 0-32 0-66 0-58 0*95 0 70
23 1-20 . 040 . 0-80 0-82 . 100 . 0-72
The following abbreviations are used: K. kynurenine; 3 OHK, 3-hydroxykynurenine; 3 OHAA
3-hydroxyanthranilic acid; oAHA, o-aminohippuric acid; KA, kynurenic acid; XA, xanthurenic
acid.
* Values refer to urine directly collected from kidney which was the site of the tumour.
Underlined values refer to abnormally high excretion.
The data, reported in Table III, show that in some subjects the exeretory
pattern ofall metabolites is perfectly normal before surgical excision of tumour.
Several workers (Boyland and Williams, 1956; Price, 1958; Tompsett, 1959;
Mainardi and Tenconi, 1964; Musajo and Benassi, 1964) agree that all humans
fed a free diet excrete daily small amounts oftryptophan metabolites. According
to a method recently set up in this laboratory (Benassi et al., 1963-64) the mean
excretion of 20 normal individuals can be summarized as follows:
TABLE IVT
Average (Range)
Metabolites (rng./day)
Kynurenine . . . . 1-14 (0 3-2 6)
3-Hydroxykynurenine . . 049 (0 0-2 3)
Kynurenic acid . . . 2-83 (1 0-4.2)
Xanthurenic acid . . 0-66 (0-3-1-8)
o-Aminohippuric acid . 1-14 (0-4-1-7)
3-Hvdroxyanthranilic acid . 0-36 (0- 11- 1)TRYPTOPHAN METABOLISM IN RENAL CARCINOMA
The comparisoni betweeni Tables III and IN' shows that in some kidney tumour
patients there are levels of some metabolites grossly exceeding the normal values.
Cases No. 6, No. 7, No. 14, No. 19 and No. 20 excrete abnormally, large amounts
ofkynurenine and cases No. 8 aind No. 12 have excess of3-hydroxyanithranilic acid
anid case No. 18 excretes high levels of 3-hydroxyanthranilic acid anid kynureniine.
Case No. 15 shows exceptionally elev7ated levels of o-aminiohippuric and also of
ki vnureniic and xanithureniic acids.
In case No. 1 0 it was possible to examine urine passed per urethram and urine
from the neoplastic kidney obtainied through ani ureteric catheter: both normal
anid neoplastic kidneys excrete dailv the same quantities of metabolites and.
except for 3-hydroxykynurenine and o-aminohipptiric acid, in an abnormal manner.
This finding is better and confirmatory evidence of the previous results that no
relationship exists between metabolite exeretion and kidney pathology and neither
is there a relationship between the metabolites and the kidniey's own enzymes.
Upon tryptophan loading in a patient with a small hvpernephroma in the left
kidney. Kerr et al. (1 l963) found, in contrast to the present result, that the
'carciniogen" (i.e. :3-hydroxykynurenine and 3-hydroxyanthranilic acid) out-
pl)t and the ratio between ' carcinogen " metabolites of tryptophan in differenit
iireteric catheter collections over a fifteen minute period was 50 O% more on the
kidniey with carcinoma. It should be noted that these results were obtained
under different conditions to those presented here sinice our results relate only to
sponitan-eous metabolite exeretion.
The values obtained by us on the spontaneous exeretioni do not indicate that
formation oftryptophan metabolites is attributable to enzyme activity oftumours.
since we have demonstrated absence of tryptophan pyrrolase and comparable
activities of kvnureninase and kynurenine transaminase in normal anld neoplastic
kidniey tissues. We think that these values for spontaneous metabolite excretion,
When abnormal, are not ascribable to tumour enzymic activity.
Moreover one must remember that persistence of abnormal levels of urinary
mnetabolites was founid by us for periods of monthls anid vears after the excision
of renal and bladder cancer.
Finally the more frequently occurring metabolites in abnlormal amounts do
nlot have the o-aminopheniol structure and are not generally considered carcino-
(genic. An abnormal increase is however neither constant nor exclusive for
urinary tract nieoplasia. In fact, a similar situation occurs in persons with cancer
in other sites anid in all patients so far investigated with Hodgkin's disease
(Crepaldi and Parpajola, 1 964).
The data in the present investigation lead to the conclusioni that tryptophani
metabolites. when present in abnormal amounts in urine of kidney tumour
patients, must n1ot be regarded as derived from the tumour's own catabolism.
SUM-MARY
TrYptopPhal pyrrolase kyvnureninase and kynurleninle tranisaminase activities
lhave been determined in 23 renal parenchymal tumours and, from 6 of these
kidneys, normal tissue was obtained for comparison. Human kidney appears to
lack tryptophani pyrrolase whilst kynureniinase and kynurenine transaminiase
seem to have about the same activity in normal and neoplastic tissue.
The determinationi of tryptophan metabolites in urine collected 24 hours
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before nephrectomy shows that some patients excrete all metabolites in niormal
amounts and in other subjects there are increased excretions of one or more
metabolites.
The data exclude a direct relationship betweeni the formation of urinary
tryptophan metabolites and any particular enzvme activity of the tumour conl-
cerned in tryptophan degradation.
We wish to express our gratitude to Professor L. Musajo for his continuous
initerest throughout these investigations and to Professor G. Ravasini for valuable
discussions.
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